Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Baghai-Ravary, J. Quint, J. Goldring, J. Hurst, G. Donaldson, J. Wedzicha (London, United Kingdom). Resolution of isolated compared to recurrent COPD exacerbations. Eur Respir J 2008; 32: Suppl. 52, 256

Member's Comments

No comment yet.

Related content which might interest you: Management of acute COPD exacerbations Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Management of COPD exacerbations Source: ERS Lung Science Conference 2019 Year: 2019 Rehospitalizations for an acute exacerbation among patients with COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Treatment of infection in COPD exacerbations Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases Year: 2014 Predictors of exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Bacterial infections in patients with acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive? Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013 Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Microorganisms isolated in COPD patients hospitalised for acute exacerbations and their clinical correlations Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012